The direct action of 1α,25(OH)2-vitamin D3 on purified mouse Langerhans cells

Cellular Immunology

Volumn 245, Issue 2, 2007, Pages 70-79

  Fujita, Hideki ^a,b   Asahina, Akihiko ^a,b   Komine, Mayumi ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Antigen presenting cells; Chemokine; Cytokine; Dendritic cells; Inflammation; Langerhans cells; Psoriasis; Skin; Vitamin D

Indexed keywords

B7 ANTIGEN; CALCITRIOL; CCL22 CHEMOKINE; CD40 ANTIGEN; CD86 ANTIGEN; CELL SURFACE PROTEIN; CHEMOKINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; PROTEIN I AD; REAGENT; SECONDARY LYMPHOID TISSUE CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG; BETA CHEMOKINE; CHEMOKINE CCL22; CYTOKINE; DIFFERENTIATION ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL 6 MOUSE; CELL CULTURE; CELL FUNCTION; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; LANGERHANS CELL; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; T LYMPHOCYTE; TH2 CELL; ANIMAL; APOPTOSIS; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; DOWN REGULATION; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MIXED LYMPHOCYTE CULTURE;

MURINAE;

ANIMALS; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CALCITRIOL; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CC; CHEMOTAXIS; CYTOKINES; DOWN-REGULATION; FEMALE; INTERLEUKIN-10; LANGERHANS CELLS; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 34250371044     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.03.007     Document Type: Article

References (50)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.-J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
3. Wu L., Vandenabeele S., and Georgopoulos K. Derivation of dendritic cells from myeloid and lymphoid precursors. Int. Rev. Immunol. 20 (2001) 117-135
4. Tada Y., Asahina A., Nakamura K., Tomura M., Fujiwara H., and Tamaki K. Granulocyte/macrophage colony-stimulating factor inhibits IL-12 production of mouse Langerhans cells. J. Immunol. 164 (2000) 5113-5119
5. Tada Y., Asahina A., Nakamura K., Miyazono K., Tomura M., Fujiwara H., and Tamaki K. Transforming growth factor-β up-regulates CD40-engaged IL-12 production of mouse Langerhans cells. Eur. J. Immunol. 31 (2001) 294-300
6. Mitsui H., Watanabe T., Saeki H., Mori K., Fujita H., Tada Y., Asahina A., Nakamura K., and Tamaki K. Differential expression and function of toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J. Invest. Dermatol. 122 (2004) 95-102
7. Tada Y., Asahina A., Fujita H., Mitsui H., Torii H., Watanabe T., and Tamaki K. Differential effects of LPS and TGF-β on the production of IL-6 and IL-12 by Langerhans cells, splenic dendritic cells, and macrophages. Cytokine 25 (2004) 155-161
8. Fujita H., Asahina A., Mitsui H., and Tamaki K. Langerhans cells exhibit low responsiveness to double-stranded RNA. Biochem. Biophys. Res. Commun. 319 (2004) 832-839
9. Tada Y., Asahina A., Fujita H., Sugaya M., and Tamaki K. Langerhans cells do not produce IFN-γ. J. Invest. Dermatol. 120 (2003) 891-892
10. Fujita H., Asahina A., Sugaya M., Nakamura K., Gao P., Fujiwara H., and Tamaki K. Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells. J. Invest. Dermatol. 124 (2005) 343-350
11. Fujita H., Asahina A., Tada Y., Fujiwara H., and Tamaki K. Type I interferons inhibit maturation and activation of mouse Langerhans cells. J. Invest. Dermatol. 125 (2005) 126-133
12. 3 analogs as immunomodulatory agents. Trends Mol. Med. 8 (2002) 174-179
13. Deluca H.F., and Cantorna M.T. Vitamin D: its role and uses in immunology. FASEB J. 15 (2001) 2579-2585
14. Norman A.W., Ishizuka S., and Okamura W.H. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J. Steroid Biochem. Mol. Biol. 76 (2001) 49-59
15. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Slznick S.H., Dominguez C.E., and Jurutka P.W. The nuclear vitamin D receptor: biological and molecular regulatory properties reserved. J. Bone. Miner. Res. 13 (1998) 325-349
16. Provvedini D.M., Tsoukas C.D., Deftos L.J., and Manolagas S.C. 1,25-Dihydroxyvitamin D3 receptor in human leukocytes. Science 221 (1983) 1181-1183
17. Brennan A., Katz D.R., Nunn J.D., Barker S., Hewison M., Fraher L.J., and O'Riordan J.L. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 61 (1987) 457-461
18. 3 receptors in normal and psoriatic skin. J. Invest. Dermatol. 97 (1991) 230-239
19. 3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin. J. Invest. Dermatol. Symp. Proc. 1 (1996) 72-77
20. Veldman C.M., Cantorna M.T., and DeLuca H.F. Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch. Biochem. Biophys. 374 (2000) 334-338
21. van de Kerkhof P.C., and Vissers W.H. Established treatment of psoriasis. Curr. Drug Targets Inflamm. Allergy 3 (2004) 145-156
22. Adorini L., Penna G., Giarratana N., Roncari A., Amuchastegui S., Daniel K.C., and Uskokovic M. Dendritic cells as key targes for immunomodulation by vitamin D receptor ligands. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 437-441
23. 3 and its analogs on dendritic cell function. J. Cell Biochem. 88 (2003) 323-326
24. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164 (2000) 2405-2411
25. Griffin M.D., Lutz W.H., Phan V.A., Bachman L.A., Mckean D.J., and Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 270 (2000) 701-708
26. 3 inhibits dendritic cell differentiation and maturation in vitro. Experimental Hematology 28 (2000) 575-583
27. 3 affects differentiation, maturation, and function of human monocyte-derived dendritic cell. J. Immunol. 164 (2000) 4443-4451
28. 3. Involvement of NFκB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101 (1998) 252-262
29. 3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 178 (2007) 145-153
30. 3 on Langerhans cells and contact hypersensitivity in mice. Arch. Dermatol. Res. 284 (1992) 368-370
31. 3 on allogenic lymphocyte stimulation and Langerhans cell maturation. Arch. Dermatol. Res. 290 (1998) 540-546
32. 3 and analogue calcipotriol on epidermal cells. Br. J. Dermatol. 130 (1994) 424-431
33. Salgado C.G., Nakamura K., Sugaya M., Tada Y., Asahina A., Koyama Y., Irie S., and Tamaki K. Functional CD40 ligand is expressed on epidermal Langerhans cells. J. Leukoc Biol. 66 (1999) 281-285
34. Kuroda E., Sugiura T., Okada K., Zeki K., and Yamashita U. Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC. J. Immunol. 166 (2001) 1650-1658
35. Gao P., Zhou X.-Y., Yashiro-Ohtani Y., Yang Y.-F., Sugimoto N., Ono S., Nakanishi T., Obika S., Takeshi I., Egawa T., Nagasawa T., Fujiwara H., and Hamaoka T. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3. J. Leukoc Biol. 73 (2003) 273-280
36. Salgado C.G., Nakamura K., Sugaya M., Tada Y., Asahina A., Fukada S., Koyama Y., Irie S., and Tamaki K. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, B7-2 expression on purified epidermal Langerhans cells. J. Invest. Dermatol. 113 (1999) 1021-1027
37. Fujita H., Asahina A., Gao P., Fujiwara H., and Tamaki K. Expression and regulation of RANTES/CCL5, MIP-1α/CCL3, and MIP-1β/CCL4 in mouse Langerhans cells. J. Invest. Dermatol. 122 (2004) 1331-1333
38. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free condition. J. Invest. Dermatol. 86 (1986) 709-714
39. 3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes. Arch. Dermatol. Res. 291 (1999) 500-506
40. Haugen J.D., Pittelkow M.R., Zinsmeister A.R., and Kumar R. 1alpha,25-Dihydroxyvitamin D3 inhibits normal human keratinocyte growth by increasing transforming growth factor beta 2 release. Biochem. Biophys. Res. Commun. 229 (1996) 618-623
41. Fukuoka M., Ogino Y., Sato H., Ohta T., Komoriya K., Nishioka K., and Katayama I. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br. J. Dermatol. 138 (1998) 63-70
42. Koizumi H., Kaplan A., Shimizu T., and Ohkawara A. 1,25-Dihydroxyvitamin D3 and a new analogue, 22-oxacalcitriol, modulate production and interleukin-8 secretion of normal human keratinocytes. J. Dermatol. Sci. 15 (1997) 207-213
43. Saeki H., Moore A.M., Brown M.J., and Hwang S.T. Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162 (1999) 2472-2475
44. Weiss J.M., Sleeman J., Renkl A.C., Dittmar H., Termeer C.C., Taxis S., Howells N., Hofmann M., Kohler G., Schopf E., Ponta H., Herrrlich P., and Simon J.C. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137 (1997) 1137-1147
45. Campbell J.J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P., Andrew D.P., Warnke R., Ruffing N., Kassam N., Wu L., and Buthcer E.C. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400 (1999) 776-780
46. 3 analog. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 443-448
47. 3 and glucocorticoid pathways. Biochem. Biophys. Res. Commun. 297 (2002) 645-652
48. D'Ambrosio D., Sinigaglia F., and Adorini L. Special attractions for suppressor T cells. Trends Immunol. 24 (2003) 122-126
49. Bystry R.S., Aluvihare V., Welch K.A., Kallikourdis M., and Betz A.G. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2 (2001) 1126-1132
50. Giarratana N., Penna G., Amuchastegui S., Mariani R., Daniel K.C., and Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J. Immunol. 173 (2004) 2280-2287